Showing results (311-320 of 406) with videos related to

Sort By:
Pageof 41
Neuro-Oncology Advances|June 18, 2021
Prospective prediction of clinical drug response in high-grade gliomas using an ex vivo 3D cell culture assayStephen Shuford, Lindsay Lipinski, Ajay Abad, et al.
Brain Pathology (Zurich, Switzerland)|November 13, 2018
Clinicopathologic features of anaplastic myxopapillary ependymomasJulieann C Lee, Nima Sharifai, Sonika Dahiya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2022
CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in GliomaAnupam Kumar, Esraa Mohamed, Schuyler Tong, et al.
Neuro-Oncology|October 24, 2015
Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539C Leland Rogers, Arie Perry, Stephanie Pugh, et al.
Frontiers in Oncology|October 17, 2022
Molecular testing for adolescent and young adult central nervous system tumors: A Canadian guidelineMary Jane Lim-Fat, Maria Macdonald, Sarah Lapointe, et al.
Current Oncology (Toronto, Ont.)|April 25, 2025
Canadian Expert Consensus Recommendations for the Diagnosis and Management of Glioblastoma: Results of a Delphi StudyWarren P Mason, Rebecca A Harrison, Sarah Lapointe, et al.
Cancer Research|November 5, 2016
Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation ProcessShigeo Ohba, Joydeep Mukherjee, Tor-Christian Johannessen, et al.
Endocrine Pathology|October 10, 2024
High-Grade Progression, Sarcomatous Transformation, and/or Metastasis of Pituitary Neuroendocrine Neoplasms (PitNENs): The UCSF ExperienceMerryl Terry, Minh P Nguyen, Vivian Tang, et al.
Neuro-Oncology|December 26, 2023
Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working GroupSabine Mueller, Jason Fangusaro, Arzu Onar Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2013
Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistanceArman Jahangiri, Michael De Lay, Liane M Miller, et al.
Pageof 41